411 related articles for article (PubMed ID: 17900673)
1. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
Runz S; Keller S; Rupp C; Stoeck A; Issa Y; Koensgen D; Mustea A; Sehouli J; Kristiansen G; Altevogt P
Gynecol Oncol; 2007 Dec; 107(3):563-71. PubMed ID: 17900673
[TBL] [Abstract][Full Text] [Related]
2. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
3. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
[TBL] [Abstract][Full Text] [Related]
4. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
[TBL] [Abstract][Full Text] [Related]
5. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16, p53, CD24, EpCAM and calretinin in serous borderline tumors of the ovary.
Aktaş IY; Buğdayci M; Usubütün A
Turk Patoloji Derg; 2012; 28(3):220-30. PubMed ID: 23011824
[TBL] [Abstract][Full Text] [Related]
7. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
9. [Isolation, identification and clinical significance of ascites-derived exosomes from patients with ovarian epithelial cancer].
Peng P; You Y; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):268-72. PubMed ID: 19570464
[TBL] [Abstract][Full Text] [Related]
10. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
[TBL] [Abstract][Full Text] [Related]
11. CD24 is a marker of exosomes secreted into urine and amniotic fluid.
Keller S; Rupp C; Stoeck A; Runz S; Fogel M; Lugert S; Hager HD; Abdel-Bakky MS; Gutwein P; Altevogt P
Kidney Int; 2007 Nov; 72(9):1095-102. PubMed ID: 17700640
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells.
Gutwein P; Stoeck A; Riedle S; Gast D; Runz S; Condon TP; Marmé A; Phong MC; Linderkamp O; Skorokhod A; Altevogt P
Clin Cancer Res; 2005 Apr; 11(7):2492-501. PubMed ID: 15814625
[TBL] [Abstract][Full Text] [Related]
13. CD24⁺ ovary cancer cells exhibit an invasive mesenchymal phenotype.
Kang KS; Choi YP; Gao MQ; Kang S; Kim BG; Lee JH; Kwon MJ; Shin YK; Cho NH
Biochem Biophys Res Commun; 2013 Mar; 432(2):333-8. PubMed ID: 23396061
[TBL] [Abstract][Full Text] [Related]
14. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
[TBL] [Abstract][Full Text] [Related]
15. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
[TBL] [Abstract][Full Text] [Related]
16. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Tauro BJ; Greening DW; Mathias RA; Mathivanan S; Ji H; Simpson RJ
Mol Cell Proteomics; 2013 Mar; 12(3):587-98. PubMed ID: 23230278
[TBL] [Abstract][Full Text] [Related]
17. Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro.
Seeber A; Martowicz A; Spizzo G; Buratti T; Obrist P; Fong D; Gastl G; Untergasser G
BMC Cancer; 2015 May; 15():372. PubMed ID: 25947366
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of exosomes isolated from human malignant pleural effusions.
Bard MP; Hegmans JP; Hemmes A; Luider TM; Willemsen R; Severijnen LA; van Meerbeeck JP; Burgers SA; Hoogsteden HC; Lambrecht BN
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):114-21. PubMed ID: 14975938
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.
Kim Y; Kim HS; Cui ZY; Lee HS; Ahn JS; Park CK; Park K; Ahn MJ
Anticancer Res; 2009 May; 29(5):1817-22. PubMed ID: 19443410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
